Chronic Kidney Disease Epidemic: Cost and Health Care Implications in China
Section snippets
Study Concerns From a Methodologic Standpoint
There are some issues that need to be considered when evaluating the information regarding prevalent CKD in China. The first issue is the sampling method of the study population. In our own study, the prevalence of an eGFR of less than 60 mL/min/1.73 m2 in a convenient sample of 2,310 adults aged 40 years or older from one district of Beijing was 5.2%.7 In another study from a representative sample of adults in Beijing,2 the prevalence of an eGFR of less than 60 mL/min/1.73 m2 among those older
CKD: A Big Challenge in China
Although information regarding the prevalence of CKD in China is not perfectly precise, it does suggest that CKD is a big challenge to the public health system in China and deserves intense attention.
References (28)
- et al.
Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years
Kidney Int
(2005) - et al.
Prevalence and factors associated with CKD: a population study from Beijing
Am J Kidney Dis
(2008) - et al.
Application of GFR-estimating equations in Chinese patients with chronic kidney disease
Am J Kidney Dis
(2005) - et al.
Body mass index and risk of ESRD in China
Am J Kidney Dis
(2007) - et al.
Clinical epidemiology of cardiovascular disease in chronic renal disease
Am J Kidney Dis
(1998) - et al.
Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population
Am J Kidney Dis
(2007) - et al.
Community-based study on CKD subjects and the associated risk factors
Nephrol Dial Transplant
(2009) - et al.
Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China
Nephrol Dial Transplant
(2009) - et al.
Screening for chronic kidney disease in a village of Zhejiang province
Chin J Nephrol
(2007) - et al.
Epidemiological investigation of adult chronic kidney disease in the Xishuangbanna district of Yunnan province
Chin J Nephrol
(2008)
Community-based screening for chronic kidney disease among populations older than 40 years in Beijing
Nephrol Dial Transplant
Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease
J Am Soc Nephrol
A population-based, prospective study of blood pressure and risk for end-stage renal disease in China
J Am Soc Nephrol
Blood pressure predicts risk of developing end-stage renal disease in men and women
Hypertension
Cited by (33)
CKD in China: Evolving Spectrum and Public Health Implications
2020, American Journal of Kidney DiseasesCitation Excerpt :Given the lack of corresponding national data, we extrapolated from data from the Hong Kong Diabetes Registry and estimated the potential number of Chinese mainland patients with ESKD due to DM to be approximately 1.06 million, which is much larger than the number of prevalent dialysis patients in 2015 (0.40 million).29 Because dialysis is covered by the Basic Health Insurance policy in China,30 1.06 million incident dialysis patients each year would correspond to an additional 106 billion Renminbi (RMB; about US $15.3 billion) annually. This translates to dialysis expenses of 1.59 trillion RMB in next 5 years, which would equal 1.3 times the annual government health expenditure in 2015.31
Utility of cystatin C-based equations in patients undergoing dialysis
2018, Clinica Chimica ActaCitation Excerpt :RRT is a lifesaving treatment including dialysis and renal transplantation for people with ESRD [4]. Hemodialysis (HD), the major RRT in China, accounts for 80%–85% of patients [5], with a prevalence increasing from 49 per million population in 2006 to 83 per million population in 2008 [6]. What's more, the cost of dialysis treatment alone for one patient would be about $14,300 per year in China [6], posing a substantial burden on patients.
Chronic kidney disease: Global dimension and perspectives
2013, The LancetCitation Excerpt :The annual cost of dialysis treatment in China is around US$14 300 per patient. Although the Chinese Government plans to institute insurance schemes, patients in rural areas would still have to pay 35–45% of the cost, which will be prohibitive for most people.81 In India, the cost of a dialysis session varies from US$20 to $60, dependent on the type of facility.80
Prevalence of chronic kidney disease in China: A cross-sectional survey
2012, The LancetCitation Excerpt :For example, the prevalence of stage 3 chronic kidney disease was 1·6% in our study, compared with 7·7% in the USA and 4·2% in Norway. One explanation might be that hypertension and diabetes have increased rapidly in the past 15–20 years in China,21 but for these diseases to affect chronic kidney disease at a population level might take another 10 years.21 This lag provides a unique opportunity to slow the increase of chronic kidney disease prevalence caused by the changing epidemiology of hypertension and diabetes in China.
Enter the dragon: A Chinese epidemic of chronic kidney disease?
2012, The Lancet